Lumosa Therapeutics Co., Ltd. (6535)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
92. 10
+1.3
+1.4317%
NT$
- Market Cap
- P/E Ratio
104% Div Yield
165,459 Volume
- Eps
NT$ 90.8
Previous Close Want to track 6535 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
6535 Earnings Reports FAQ
What is the earnings per share (EPS) for 6535?
EPS data for 6535 is currently not available, as Lumosa Therapeutics Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Lumosa Therapeutics Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Lumosa Therapeutics Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lumosa Therapeutics Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 6535 at this time, as Lumosa Therapeutics Co., Ltd has no recent EPS data to calculate it.
